Literature DB >> 6131106

Purification and characterization of the heat-stable factors essential for the conversion of lignoceric acid to cerebronic acid and glutamic acid: identification of N-acetyl-L-aspartic acid.

H Shigematsu, N Okamura, H Shimeno, Y Kishimoto, L Kan, C Fenselau.   

Abstract

The conversion of lignoceric acid to cerebronic acid, ceramides, cerebrosides, and glutamic acid is catalyzed by a rat brain particulate preparation. The heat-stable factor, prepared from calf cerebellum, together with the heat-labile factor, a pyridine nucleotide, and Mg2+ are essential to all of these metabolic pathways. Our previous work showed that the heat-stable factor is composed of at least two components, HSF-1 and HSF-2, and identified HSF-2 as D-glucose-6-phosphate. In the current investigation, HSF-1 was further purified and found to be N-acetyl-L-aspartic acid. In addition, it was discovered that a third component, HSF-3, is also required for heat-stable factor activity. A reconstituted system composed of N-acetylaspartic acid, glucose-6-phosphate, and HSF-3 fully replaced the heat-stable factor essential for the conversion of lignoceric acid to cerebronic acid and glutamic acid. The reconstituted heat-stable factor did not show the initial time lag always observed with the crude heat-stable factor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131106     DOI: 10.1111/j.1471-4159.1983.tb08052.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

2.  Quantification of N-acetyl-L-aspartic acid in urine by isotope dilution gas chromatography-mass spectrometry.

Authors:  R I Kelley; J N Stamas
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  N-acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid.

Authors:  K F Faull; R Rafie; N Pascoe; L Marsh; A Pfefferbaum
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

4.  N-acetylaspartic aciduria due to aspartoacylase deficiency--a new aetiology of childhood leukodystrophy.

Authors:  L Hagenfeldt; I Bollgren; N Venizelos
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

5.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

6.  Biochemical diagnosis of Canavan disease.

Authors:  G Bartalini; M Margollicci; P Balestri; M A Farnetani; M Cioni; A Fois
Journal:  Childs Nerv Syst       Date:  1992-12       Impact factor: 1.475

7.  Alpha-hydroxylation and oxidation of lignoceric acid in brain: the role of heat-stable and heat-labile factors.

Authors:  H Shimeno; A Wali; Y Kishimoto
Journal:  Neurochem Res       Date:  1984-02       Impact factor: 3.996

Review 8.  Canavan disease: biochemical and molecular studies.

Authors:  R Matalon; R Kaul; K Michals
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Determination of gangliosides as 2,4-dinitrophenylhydrazides by high-performance liquid chromatography.

Authors:  K Miyazaki; N Okamura; Y Kishimoto; Y C Lee
Journal:  Biochem J       Date:  1986-05-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.